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Abstract
Summary The prevalence of vertebral fractures on routine
chest radiographs of elderly Caucasian women was only
1.3 times higher than in African American (AA) women,
a difference considerably smaller than reported in
population studies. AAs with medical problems may
have higher risk of vertebral fractures than previously
suspected.
Introduction Earlier studies noted a 1.9- to 3.7-fold higher
prevalence of vertebral fractures in Caucasian (CA) compared
to African American (AA) women. These studies, however,
mayhavesufferedfromselectionbias.Wereportedthatamong
women referred for bone density testing, the prevalence of
vertebral fractures in AA was the same as in CA women.
Suspectingthatthelattermighthavebeenduetoareferralbias,
we examined the racial difference in the prevalence of vertebra
fractures on chest radiographs of patients seeking general
medical care, not selected for osteoporosis.
Methods Consecutive chest radiographs (N=1,200) of
women over age 60 were evaluated using Genant"s semi-
quantitative method. Patients" race and the presence of
diseases or medications associated with increased fracture
risk were ascertained from the electronic medical records.
Results Among 1,011 women (76% AA) with usable radio-
graphs, 11% had moderate or severe vertebral fractures. The
prevalence of vertebral fractures was 10.3% in 773 AA and
13% in 238 CA women (p=0.248 for difference between
races). The lack of difference persisted after controlling for
age, smoking, use of glucocorticoids, or presence of cancer,
rheumatoid arthritis, organ transplantation, and end-stage
renal disease. Among all subjects, CA women were more
likely to be diagnosed and treated for osteoporosis (p<0.001).
Conclusion Among subjects seeking medical care, the
difference in the prevalence of vertebral fractures between
AA and CA women is smaller than previously suspected.
Greater attention to the detection of vertebral fractures and
the management of osteoporosis is warranted in AAwomen
with medical problems.
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Vertebral fractures are important to detect because they are
associated with significant morbidity, mortality, and re-
duced quality of life [1, 2] and because they strongly
predict future fractures [3–6] and are considered diagnostic
of osteoporosis. Clinical vertebral fractures (i.e., those that
are clinically recognized) comprise only one third of all
fractures found on radiographs [7–9]. However, radiograph-
ic vertebral fractures are also indicative of osteoporosis and
predictive of future fracture risk. Therefore, spine imaging
is necessary to assess the true prevalence of vertebral
fractures in a given population. Knowing the prevalence of
vertebral fractures in different populations aids the quanti-
fication of the osteoporotic burden and facilitates better
management of this condition.
It is generally accepted that compared to Caucasian
Americans (CA), African Americans (AA) have a lower
risk of osteoporotic fractures. Consequently, AA are less
likely to undergo appropriate diagnostic procedures or
receive therapies for osteoporosis even when they present
with fractures or use medications that cause bone loss [10–
12]. In 1997, Jacobsen et al. analyzed Medicare discharge
diagnoses and reported higher rates of clinical vertebral
fractures in CA than in AAwomen (17.1 vs. 3.7 per 10,000
per year) [13]. The authors acknowledged that these results
might have been partly due to a bias if physicians suspected
vertebral fractures and performed necessary imaging in CA
patients but not in AA patients presenting with back pain. A
different kind of bias may affect population studies of
osteoporosis, most of which focused on CA women with
under-representation of AA women. Two such studies have
examined vertebral fractures. The National Osteoporosis
Risk Assessment reported numerically higher 1-year inci-
dence of clinical vertebral fractures in CA than in AA
women (0.185% vs. 0.12%), but the difference was not
statistically significant [14]. In the study of osteoporotic
fractures, the prevalence of vertebral fractures was higher in
CA than in AA women (19.1% vs. 10.6%) [15]. However,
population studies tend to enroll relatively healthier
subjects in general, and this may be particularly true for
AA participants. As a result, the difference in the health
level between the study subjects and that of the general
population may be exaggerated for AA subjects.
We have observed that among women referred for bone
densitometry at a university hospital with a large percentage
of AA patients, the prevalence of vertebral fractures was
similar in AA and CA women [16]. This may be due to a
referral bias if AA women are referred for bone mineral
density when their treating physician has high suspicion for
fractures while CA women are referred for screening
purposes. Alternatively, the true prevalence of vertebral
fractures in AA may be underestimated in the above-
mentioned population studies, which may have preferen-
tially recruited healthier subjects. Chest radiographs have
previously been utilized to examine the under-reporting of
vertebral fractures [9, 17, 18] and can be used to estimate
disease prevalence in subjects not selected for osteoporosis
screening. To obtain an unbiased estimate of racial differ-
ences in vertebral fracture burden in subjects seeking
medical care, we examined the prevalence of vertebral
fractures on lateral chest radiographs obtained for routine
clinical purposes.
Methods
All consecutive chest radiographs from women over the age
of 60 were collected for the calendar years of 2005 and 2006
and sorted by medical record number (MRN). The first 600
MRNs from 2005 and the first 600 MRNs from 2006 were
included in the study. Electronic medical records were used to
obtain clinical information for each patient whose radiograph
was included in the analysis. The study was approved by the
University of Chicago"s Institutional Review Board.
Evaluation of radiographs
The chest radiographs were available in digital form and
accessed using Philips iSite v. 3.3.2 (Stentor). Evaluation of
radiographs was done without knowledge of the race or other
clinical characteristics of the patients. Vertebral fractures were
classified using Genant"s semi-quantitative scale [19], which
defines a grade 1 fracture as a loss of vertebral height of 20–
25%, grade 2 as a loss of 26–40%, and grade 3 as a loss of
greater than 40%. A spinal deformity index (SDI) was
calculated for each patient as the sum of the fracture grades
of all vertebrae from that patient [20]. Patients with an SDI
of at least 2 were classified as having a fracture.
Information from the medical records
Electronic medical records were used to ascertain the race of
the patient, when available, as well as the presence of
conditions or use of medications that may be associated with
an increased risk of fractures including: a history of cancer,
use of systemic (but not inhaled) glucocorticoids, rheumatoid
arthritis, organ transplantation, end-stage renal disease
(ESRD), and cigarette smoking. It was also noted whether
the patient had a bone mineral density (BMD) result available
in the electronic record, and if so, whether there was
osteoporosis by BMD defined as a T-score of ≤−2.5 at the
lumbar spine, femoral neck, or total hip. A diagnosis of
osteoporosisby medical record was present if the diagnosis of
osteoporosis was recorded in the physicians" notes. Treatment
of osteoporosis was present if the patient was receiving
2366 Osteoporos Int (2011) 22:2365–2371calcium, with or without vitamin D, or pharmacologic
therapy for osteoporosis (bisphosphonates, estrogen, ralox-
ifene, teriparatide, or calcitonin). It should be noted that at
the time of the study, the electronic medical record contained
the progress notes only for some clinics, and the ascertain-
ment of the medication use and medical problems present
may thus be incomplete.
Statistical analysis
Statistical analyses were performed using STATA 10
(StataCorp, College Station, TX) software. Differences
between AA and CA patients were examined using a t test
for continuous and chi-squared test for categorical varia-
bles. Logistic regressions were used to determine whether
the observed difference in the prevalence of vertebral
fractures between the AA and CA women could be
explained by medical conditions associated with osteopo-
rosis (see above). In these logistic regression analyses,
presence of vertebral fractures (yes or no) was a binary
outcome while race (AA or CA) and age were fixed
predictors in all models. The conditions associated with
osteoporosis were then added one at a time to the model as
covariates. In addition, interaction terms with race were
generated for each of these covariates and added into the
model along with the respective covariate, race, and age.
Results
After eliminating duplicate exams from the same patients,
uninterpretable images, women who were not AA or CA, or
patients without a race specified, there were 1,011 subjects
left for analysis. Their clinical characteristics are shown in
Table 1. The two racial groups did not differ in age,
prevalence of rheumatoid arthritis, previous organ trans-
plantation, or systemic glucocorticoid usage. CA women
were more likely to have a history of cancer, but they had a
lower prevalence of end-stage renal disease and smoking. A
higher percentage of AA received their primary care at the
University of Chicago Medical Center.
There was no statistically significant difference between
the races in the vertebral fracture prevalence (Table 1 and
Fig. 1) or vertebral fracture burden measured by the spinal
deformity index (SDI of 3.2±2.3 in AA vs. 3.4±2.0 in CA
women with vertebral fractures, p=0.66). When the data
were stratified according to decade of age (60–69, 70–79,
and 80 years and older), the fracture prevalence was
significantly higher in CA than in AA aged 60–70 years
but not in the older age strata (Fig. 1). The prevalence of
vertebral fractures increased with age in AA but not in CA
women in whom the prevalence of vertebral fractures was
relatively higher in 60–70 years old compared to the older
women (Fig. 1). The proportion of women who had the
diagnosis of cancer decreased with age in CA women,
although this difference was not statistically significant (p=
0.3). The lack of age-related increase in the prevalence of
vertebral fractures was observed in CAwomen with as well
as those without cancer.
The conditions from Table 1 that may influence vertebral
fracture risk were examined separately in patients with
vertebral fractures. Although there were differences in the
frequency of these conditions in the whole population,
these differences did not reach statistical significance when
the analysis was restricted to women with vertebral
fractures (data not shown).
We used logistic regression to determine whether the
lack of a significant racial difference in the prevalence of
vertebral fractures could be explained by a differential
burden of conditions associated with osteoporosis. In
these logistic regression models, the presence of vertebral
fracture(s) was an outcome variable, race and age were
fixed predictors, and each of the clinical characteristics
from Table 1 was added individually to the model as a
covariate. There was no significant effect of any of the
clinical conditions and no significant interaction of these
clinical variables with race.F u r t h e r m o r e ,t h ep o i n t
estimates for race (coefficients) in the regression models
Clinical characteristic Caucasian (N=238) African American (N=773) p value
Age (years) 74.9±8.5 74.5±8.7 0.50
Vertebral fracture 31 (13.0%) 80 (10.4%) 0.26
Cancer 85 (35.7%) 147 (19.0%) <0.001
Rheumatoid arthritis 6 (2.5%) 20 (2.6%) 0.96
ESRD 3 (1.3%) 43 (5.6%) 0.005
Transplant 5 (2.1%) 9 (1.2%) 0.28
Glucocorticoids 20 (8.4%) 44 (5.7%) 0.13
Smoking 40 (18.5%) 223 (28.9%) 0.002
PCP at Univ. of Chicago 117 (49.2%) 522 (67.5%) <0.001
Table 1 Clinical characteristics
of 1,011 women whose chest
radiographs were used in analysis
The results are given as mean±
standard deviation for continuous
variables and number (percent) for
categorical variables. p values are
from t test for continuous and chi-
square test for categorical variables
ESRD end-stage renal disease,
PCP primary care physician
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clinical conditions.
While cancer was more prevalent in CA women, the
racial differences in vertebral fractures were similar in
women with and without cancer (Fig. 2a). Although among
all subjects, smoking was more common in the AA group,
the rates of smoking did not differ between AA and CA
women with vertebral fractures. When stratifying the
analysis by smoking, the racial difference in vertebral
fracture prevalence was more pronounced in smokers,
although the difference did not reach statistical significance
(Fig. 2b). ESRD was more common among AA women.
However, the difference in the prevalence of vertebral
fractures between the two racial groups was similar in 965
subjects without ESRD (10% in AA vs. 13.2% in CA, p=
0.2) and in the whole population. The racial difference in
vertebral fracture prevalence was more pronounced in
women with history of systemic glucocorticoid use than
in those without (Fig. 2c), although this was not statistically
significant. The prevalence of vertebral fractures did not
differ between subjects who had and those who did not
have primary care physician at the University of Chicago
(Fig. 2d).
Less than half of the subjects had results of BMD testing
in the medical record with no racial difference in the
percentage of subjects tested (Table 2). CA women were
more likely to have a BMD diagnosis of osteoporosis
defined as T-scores ≤−2.5 at either the lumbar spine or the
proximal femur. CAwomen were also more likely to have a
diagnosis of osteoporosis recorded in the medical record
and to receive treatment for osteoporosis (Table 2). Similar
trends were observed in women with vertebral fractures
(Table 3). Higher proportions of CA women received
pharmacologic treatment for osteoporosis (p=0.02).
Only 18% of patients with vertebral fractures found on
chest radiographs in this study had vertebral fractures
mentioned in the radiology report, with no significant
difference between the races.
Discussion
We have previously observed that among patients
referred for bone density testing at the University of
Chicago, the prevalence of vertebral fractures was similar
in AA and CA women [16]. In contrast, population
studies reported that the prevalence of vertebral fractures
in CA women was 1.9- to 2.3-fold higher [14, 15]. Since
population studies often recruit subjects who are relatively
healthier than the general population and certainly health-
ier than subjects who are seeking medical care, we wanted
to obtain an unbiased estimate of true racial difference in
the prevalence of vertebral fractures in patients cared for at
a medical facility. To this end, we examined consecutive
chest radiographs of elderly AA and CAwomen and found
that the racial difference in vertebral fracture prevalence
was considerably smaller (only 1.3-fold higher in CA
women) and not statistically significant. We then investi-
gated whether this unexpected observation could be
explained by differences in medical conditions which lead
p=0.2 
p=0.04 
p=0.97 
p=0.99 
Fig. 1 Prevalence of vertebral
fractures according to age in
Caucasian and African
American women. The absolute
numbers of patients with
fractures are shown above each
bar graph together with the
number of patients in respective
age/race strata
2368 Osteoporos Int (2011) 22:2365–2371to osteoporosis and vertebral fractures. Our results suggest
that this is not the case.
The two races were similar in age, which is a known
strong predictor of vertebral fractures. When medical
conditions that may be associated with fractures (Table 1)
were added as covariates to regression analyses with
vertebral fractures as outcome, and race and age as fixed
predictors, the point estimates (coefficients) for race did not
change. None of the medical conditions examined had a
significant effect in the regression models or significant
interaction with race. Cancer was present in a higher
proportion of CA women. However, that should result in a
greater, rather than smaller, difference in the vertebral
fracture prevalence between CA and AA women, assuming
that some of the fractures are due to malignant causes or to
osteoporosis resulting from treatment for malignancy. The
AA group had higher prevalence of ESRD, but the racial
differences in the vertebral fracture prevalence were similar
in patients without ESRD and in the whole study sample.
We also observed higher prevalence of smoking in the AA
subjects. Interestingly, we found greater (albeit not statis-
tically significant) racial difference in the vertebral fracture
prevalence among smokers than non-smokers (Fig. 2b). It is
possible that this was due to a difference in body weight
(lower weight in CA as compared to AA smokers) which
was not available in our study. We found grater racial
difference in vertebral fracture prevalence (again not
statistically significant) in women with history of gluco-
corticoid use (Fig. 2c). However, we did not have an
accurate estimate of the glucocorticoid dose, which makes
any conclusion regarding the racial differences in its effect
unreliable.
Caucasian (N=238) African American (N=773) p value
BMD in medical record 110 (46.2%) 317 (41.0%) 0.155
OP on BMD
a 42 (38.2%) 71 (22.4%) 0.001
OP in medical record 44 (18.5%) 64 (8.3) <0.001
Calcium±vitamin D 72 (30.3%) 104 (13.5%) <0.001
Pharmacologic therapy 55 (23.1%) 66 (8.5%) <0.001
Table 2 Osteoporosis (OP)
diagnosis and management—all
subjects
aAmong the 110 CA and 317 AA
women who had BMD testing
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Fig. 2 Prevalence of vertebral
fractures in Caucasian (open
bars) and African American
women (shaded bars) according
to presence of cancer (a),
smoking (b), use of glucocorti-
coids (GC—graph C), or having
primary care physician (PCP) at
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may be due to heterogeneity of our study sample, which
included both patients who received their primary care at
our institution and those who were referred for tertiary care.
We found similar racial differences in vertebral fracture
prevalence among patients who were and those who were
not receiving primary care at the University of Chicago
(Fig. 2d). It appears, therefore, that our observation of
smaller than expected difference in the vertebral fracture
prevalence between AA and CA women are not explained
by easily identifiable differences in health status.
Age is one of the most important risk factors for the
development of osteoporotic vertebral fractures. Therefore,
we stratified the analysis by decade and found a racial
difference only for the youngest age strata (60–70 years).
As expected, in AA, the prevalence of vertebral fractures
i n c r e a s e dw i t ha g e( F i g .1). In contrast, the fracture
prevalence in the CA group decreased between the sixth
and seventh decades before increasing again. A greater
proportion of younger CA women had the diagnosis of
cancer, but this does not fully explain our data as a similar
pattern was observed in women with and without cancer.
The reason for the unusual age distribution of vertebral
fractures in our CA subjects remains unclear and may be
due to a relatively small sample size of CA women. Based
on our data, it is possible that CA women start having
vertebral fractures at an earlier age (60–70 years old), while
the racial difference in vertebral fracture rates becomes
smaller or non-existent with more advanced age (over
70 years of age). The cross-sectional nature of our study
precludes any firm conclusions regarding this question.
The reason for a relatively higher than expected
prevalence of vertebral fractures in AA relative to CA
women in our study is thus not explained by any of the risk
factors we could assess through the medical record review.
We hypothesize that the racial differences in fracture rates
observed in healthier participants in population studies are
diminished in patients seeking medical care, who are
probably sicker. The mechanism by which “being sick”
increases fracture risk is currently unclear but may involve
low physical activity, hypogonadism, effect of other
metabolic diseases, or vitamin D deficiency. Further studies
are needed to explore these possibilities and to develop
therapeutic approaches to correct them.
A similar percentage of AA and CA subjects in our
study had BMD documented in their medical record,
which suggests that there was no major racial disparity in
screening for osteoporosis. Nevertheless, Caucasian
women were more likely to have a diagnosis of
osteoporosis in their medical records, and they were also
more likely to receive treatment for osteoporosis. Among
w o m e nw i t hv e r t e b r a lf r a c t u res, the racial differences
reached statistical significance only for treatment but not
for diagnosis of osteoporosis (Table 3). A majority of
women with vertebral fractures identified in this study
were not diagnosed with osteoporosis: only 25.8% of CA
and 16.3% of AA women with vertebral fractures had
osteoporosis mentioned in their medical record. The rates
of treatment for osteoporosis were low, particularly for AA
women (Table 3).
The fracture prevalence in our study population of 11%
is slightly lower than the 14–16% prevalence reported in
other studies of chest radiographs [9, 17]. The lower
prevalence in our study may be due to the fact that we
included both inpatient and outpatient exams while the
previous studies utilized chest radiographs of hospitalized
patients [9] or patients who presented to the emergency
room [17]. Both of these patient groups may be relatively
sicker than our study population, which included potential-
ly healthier outpatients.
There are some limitations to our study. First, because
we examined chest radiographs, we could not detect most
of the fractures in the lumbar spine. However, this is true
for both races and not likely to affect the comparison. A
second limitation is that we assessed the health status using
electronic medical records, which may be incomplete for
some of the patients, but this should affect the two races
equally. We also relied on medical records to determine the
race of a patient. Again, any errors should be randomly
distributed between the two groups.
This study also has significant strengths. It is the first
study to date to examine vertebral fractures in a population
with a large proportion of African Americans, the popula-
tion group in which osteoporosis is more likely to be under-
recognized [10, 12]. In addition, we included a thorough
review of medical records, which allowed us to examine
whether our observations may be due to racial differences
in health status.
Caucasian (N=31) African American (N=80) p value
BMD in medical record 13 (41.9%) 38 (47.5%) 0.598
OP on BMD
a 8 (61.5%) 13 (34.2%) 0.084
OP in medical record 8 (25.8%) 13 (16.3%) 0.249
Calcium±vitamin D 8 (25.8%) 15 (18.8%) 0.411
Pharmacologic therapy 12 (38.7) 14 (17.5%) 0.018
Table 3 Osteoporosis (OP)
diagnosis and management in
women with vertebral fractures
aAmong the 13 CA and 38 AA
women with fractures who had
BMD testing
2370 Osteoporos Int (2011) 22:2365–2371The results of this study may have significant implications
for the diagnosis and treatment of osteoporosis in the AA
community. AA currently receive fewer diagnostic, therapeu-
tic, and preventative measures for osteoporosis because it is
assumed that they are less affected by this disease [12]. While
this may be true for a healthy population, our results suggest
that among those seeking medical care, AA are affected by
osteoporosis at rates that are much closer to those of CA
subjects. This is consistent with a study of a COPD cohort,
which reports similar rates of vertebral fractures in AA and
CA patients [21]. Based on these findings, it may be prudent
to increase attention to osteoporosis and vertebral fractures in
AA subjects with medical problems.
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